Free Trial

Cabot (CBT) Competitors

Cabot logo
$71.99 +0.07 (+0.09%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$63.45 -8.54 (-11.86%)
As of 08:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CBT vs. UFPI, ASIX, AVNT, CC, and EMN

Should you buy Cabot stock or one of its competitors? Cabot's main competitors and comparable companies include UFP Industries (UFPI), AdvanSix (ASIX), Avient (AVNT), Chemours (CC), and Eastman Chemical (EMN). Companies are selected based on similarities in market, industry, and size.

How does Cabot compare to UFP Industries?

Cabot (NYSE:CBT) and UFP Industries (NASDAQ:UFPI) are related mid-cap companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

In the previous week, UFP Industries had 1 more articles in the media than Cabot. MarketBeat recorded 5 mentions for UFP Industries and 4 mentions for Cabot. UFP Industries' average media sentiment score of 0.98 beat Cabot's score of -0.08 indicating that UFP Industries is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cabot
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
UFP Industries
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cabot has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, UFP Industries has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

93.2% of Cabot shares are owned by institutional investors. Comparatively, 81.8% of UFP Industries shares are owned by institutional investors. 3.1% of Cabot shares are owned by company insiders. Comparatively, 2.5% of UFP Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

UFP Industries has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than UFP Industries, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cabot$3.74B0.99$213M$4.0117.95
UFP Industries$6.32B0.69$294.79M$4.1219.29

Cabot currently has a consensus price target of $83.60, indicating a potential upside of 16.13%. UFP Industries has a consensus price target of $103.25, indicating a potential upside of 29.89%. Given UFP Industries' stronger consensus rating and higher probable upside, analysts clearly believe UFP Industries is more favorable than Cabot.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cabot
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
UFP Industries
2 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.14

Cabot has a net margin of 5.69% compared to UFP Industries' net margin of 3.61%. Cabot's return on equity of 19.64% beat UFP Industries' return on equity.

Company Net Margins Return on Equity Return on Assets
Cabot5.69% 19.64% 8.68%
UFP Industries 3.61%7.53%5.68%

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.6%. UFP Industries pays an annual dividend of $1.44 per share and has a dividend yield of 1.8%. Cabot pays out 47.1% of its earnings in the form of a dividend. UFP Industries pays out 35.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and UFP Industries has raised its dividend for 5 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

UFP Industries beats Cabot on 11 of the 19 factors compared between the two stocks.

How does Cabot compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Cabot (NYSE:CBT) are both materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

AdvanSix currently has a consensus price target of $20.50, suggesting a potential upside of 30.66%. Cabot has a consensus price target of $83.60, suggesting a potential upside of 16.13%. Given AdvanSix's higher probable upside, equities analysts plainly believe AdvanSix is more favorable than Cabot.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdvanSix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Cabot
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Cabot has a net margin of 5.69% compared to AdvanSix's net margin of -1.40%. Cabot's return on equity of 19.64% beat AdvanSix's return on equity.

Company Net Margins Return on Equity Return on Assets
AdvanSix-1.40% -2.29% -1.08%
Cabot 5.69%19.64%8.68%

AdvanSix has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

In the previous week, Cabot had 1 more articles in the media than AdvanSix. MarketBeat recorded 4 mentions for Cabot and 3 mentions for AdvanSix. AdvanSix's average media sentiment score of 0.32 beat Cabot's score of -0.08 indicating that AdvanSix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AdvanSix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cabot
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 4.1%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.6%. AdvanSix pays out -76.2% of its earnings in the form of a dividend. Cabot pays out 47.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AdvanSix has increased its dividend for 2 consecutive years and Cabot has increased its dividend for 14 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and lower payout ratio.

86.4% of AdvanSix shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 5.0% of AdvanSix shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cabot has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AdvanSix$1.52B0.28$49.29M-$0.84N/A
Cabot$3.74B0.99$213M$4.0117.95

Summary

Cabot beats AdvanSix on 13 of the 19 factors compared between the two stocks.

How does Cabot compare to Avient?

Cabot (NYSE:CBT) and Avient (NYSE:AVNT) are both mid-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Cabot presently has a consensus target price of $83.60, suggesting a potential upside of 16.13%. Avient has a consensus target price of $48.75, suggesting a potential upside of 9.16%. Given Cabot's higher probable upside, equities research analysts clearly believe Cabot is more favorable than Avient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cabot
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Avient
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.6%. Avient pays an annual dividend of $1.10 per share and has a dividend yield of 2.5%. Cabot pays out 47.1% of its earnings in the form of a dividend. Avient pays out 56.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and Avient has increased its dividend for 1 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cabot has a net margin of 5.69% compared to Avient's net margin of 5.27%. Cabot's return on equity of 19.64% beat Avient's return on equity.

Company Net Margins Return on Equity Return on Assets
Cabot5.69% 19.64% 8.68%
Avient 5.27%12.17%4.95%

In the previous week, Cabot and Cabot both had 4 articles in the media. Avient's average media sentiment score of 0.99 beat Cabot's score of -0.08 indicating that Avient is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cabot
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avient
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cabot$3.74B0.99$213M$4.0117.95
Avient$3.26B1.26$81.90M$1.9522.90

93.2% of Cabot shares are held by institutional investors. Comparatively, 95.5% of Avient shares are held by institutional investors. 3.1% of Cabot shares are held by insiders. Comparatively, 0.9% of Avient shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cabot has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Avient has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

Summary

Cabot beats Avient on 11 of the 18 factors compared between the two stocks.

How does Cabot compare to Chemours?

Chemours (NYSE:CC) and Cabot (NYSE:CBT) are both materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

In the previous week, Chemours had 26 more articles in the media than Cabot. MarketBeat recorded 30 mentions for Chemours and 4 mentions for Cabot. Chemours' average media sentiment score of 0.06 beat Cabot's score of -0.08 indicating that Chemours is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
2 Very Positive mention(s)
1 Positive mention(s)
24 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cabot
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Chemours has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Chemours presently has a consensus price target of $17.36, suggesting a potential upside of 30.84%. Cabot has a consensus price target of $83.60, suggesting a potential upside of 16.13%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Cabot.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
Cabot
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Cabot has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.81B0.34-$386M-$1.02N/A
Cabot$3.74B0.99$213M$4.0117.95

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.6%. Chemours pays out -34.3% of its earnings in the form of a dividend. Cabot pays out 47.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 3.1% of Cabot shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cabot has a net margin of 5.69% compared to Chemours' net margin of -2.64%. Chemours' return on equity of 76.52% beat Cabot's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours-2.64% 76.52% 1.51%
Cabot 5.69%19.64%8.68%

Summary

Chemours beats Cabot on 10 of the 19 factors compared between the two stocks.

How does Cabot compare to Eastman Chemical?

Eastman Chemical (NYSE:EMN) and Cabot (NYSE:CBT) are both mid-cap materials companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

Eastman Chemical has a net margin of 7.15% compared to Cabot's net margin of 5.69%. Cabot's return on equity of 19.64% beat Eastman Chemical's return on equity.

Company Net Margins Return on Equity Return on Assets
Eastman Chemical7.15% 10.59% 4.28%
Cabot 5.69%19.64%8.68%

Eastman Chemical presently has a consensus price target of $74.79, suggesting a potential upside of 15.00%. Cabot has a consensus price target of $83.60, suggesting a potential upside of 16.13%. Given Cabot's higher probable upside, analysts clearly believe Cabot is more favorable than Eastman Chemical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eastman Chemical
1 Sell rating(s)
8 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.33
Cabot
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Eastman Chemical had 13 more articles in the media than Cabot. MarketBeat recorded 17 mentions for Eastman Chemical and 4 mentions for Cabot. Eastman Chemical's average media sentiment score of 0.34 beat Cabot's score of -0.08 indicating that Eastman Chemical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Eastman Chemical
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cabot
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Eastman Chemical has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

83.7% of Eastman Chemical shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 2.6% of Eastman Chemical shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Eastman Chemical has higher revenue and earnings than Cabot. Eastman Chemical is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eastman Chemical$8.75B0.85$474M$5.6311.55
Cabot$3.74B0.99$213M$4.0117.95

Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 5.2%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.6%. Eastman Chemical pays out 59.7% of its earnings in the form of a dividend. Cabot pays out 47.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Eastman Chemical has increased its dividend for 15 consecutive years and Cabot has increased its dividend for 14 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Eastman Chemical beats Cabot on 11 of the 19 factors compared between the two stocks.

Get Cabot News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CBT vs. The Competition

MetricCabotChemicals IndustryMaterials SectorNYSE Exchange
Market Cap$3.72B$11.44B$4.59B$23.55B
Dividend Yield2.62%3.00%4.31%3.78%
P/E Ratio17.9534.7627.8529.83
Price / Sales0.992.235.483.15
Price / Cash7.0014.7220.8015.64
Price / Book2.103.024.024.11
Net Income$213M$237.64M$159.75M$1.08B
7 Day Performance0.14%-0.99%-3.72%-1.58%
1 Month Performance-3.10%-1.02%-5.55%0.28%
1 Year Performance16.97%11.63%7.63%7.30%

Cabot Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CBT
Cabot
4.1585 of 5 stars
$71.99
+0.1%
$83.60
+16.1%
+17.0%$3.72B$3.74B17.954,100
UFPI
UFP Industries
4.8128 of 5 stars
$82.66
+3.4%
$103.25
+24.9%
-12.2%$4.76B$6.32B20.0613,800
ASIX
AdvanSix
4.0678 of 5 stars
$15.62
-7.2%
$20.50
+31.3%
-0.2%$419.06M$1.52BN/A1,410
AVNT
Avient
4.3169 of 5 stars
$46.35
+1.9%
$48.75
+5.2%
+52.5%$4.39B$3.26B23.779,000
CC
Chemours
4.1107 of 5 stars
$13.31
+4.4%
$17.36
+30.4%
+11.8%$2.08B$5.81BN/A5,700

Related Companies and Tools


This page (NYSE:CBT) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners